Name: Instil Bio, Inc. (TIL) Financial Statements
Creator: FinSpry

Instil Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Instil Bio, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.14
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.14
Operating Expenses
Research & Development	13.63	39.63	136.83	107.25	18.47
Selling, General & Administrative	46.33	50.91	69.34	48.31	13.48
Operating Expenses	59.96	90.54	206.17	155.56	31.95
Operating Income	-59.96	-90.54	-206.17	-155.56	-31.82
Other Income/Expense
Interest Income	6.99	8.87	3.66	0.08	0.00
Interest Expense	-8.99	-5.21	-1.88	0.00	0.00
Other Income/Expense	1.41	-0.58	-0.56	1.28	-3.94
Income
Income Before Tax	-74.14	-156.09	-225.25	-156.76	-37.59
Income Tax Expense	0.00	0.00	-2.07	0.04	0.15
Net Income	-74.14	-156.09	-223.18	-156.79	-37.74
Net Income - Continuous Operations	-74.14	-156.09	-223.18	-156.79	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-56.35	-85.79	-200.18	-154.00	-31.56
EBIT	-59.96	-90.54	-206.17	-156.76	-31.82
Depreciation & Amortization	3.61	4.76	5.99	2.70	0.26
Earnings Per Share
Basic EPS	-11.00	-24.00	-34.00	-30.00	-47.00
Diluted EPS	-11.00	-24.00	-34.00	-30.00	-47.00
Basic Shares Outstanding	6.51	6.50	6.48	5.30	0.80
Diluted Shares Outstanding	6.51	6.50	6.48	5.30	0.80